All News #Library
Rare Diseases
Tisento Therapeutics Wraps Up Global Phase 2B Zagociguat Study
08 Jan 2026 //
GLOBENEWSWIRE
Tisento Therapeutics Gets FDA Fast Track for Zagociguat for MELAS
17 Jun 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support